Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
General Atlantic is a leading global growth equity investment firm founded in 1980. It provides capital and strategic support to high-growth companies across multiple sectors including healthcare and life sciences. The firm has invested over $1 billion in the life sciences sector globally, backing both therapeutics developers and tools/services companies such as contract research organizations. Its healthcare/life sciences portfolio includes notable names like Royalty Pharma, Ginkgo Bioworks, PathAI, Immunocore, Alignment Healthcare, Vida Health, Jubilant Life Sciences and others. The company operates globally with offices across North America, Europe, Asia-Pacific, Middle East and Africa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on General Atlantic.